HCA Healthcare (HCA) FY2025 results: revenue $75.6 billion, up 7.1% on the year
HCA Healthcare, Inc. (HCA) reported revenue of $75.6 billion for fiscal 2025, the year ended 31 December 2025, up 7.1% on the year before. Net income was $6.8 billion, up 17.8%, and diluted earnings per share $28.33. The figures are the company's own, from the 10-K it filed with the SEC on 10 February 2026.
this yearthe year beforeHover a bar for its figure.
The year in brief
From this 10-K
HCA Healthcare owns and operates hospitals and other care facilities. At 31 December 2025 it ran 190 hospitals, made up of 179 general acute care hospitals, seven behavioral hospitals and four rehabilitation hospitals, along with 121 freestanding ambulatory surgery centres and 31 freestanding endoscopy centres. The facilities sit in 19 states and England. The company commenced operations in 1968 through its predecessors, was incorporated in Delaware in October 2010 and is based in Nashville, Tennessee.
The four quarters: Q1 FY2025 · Q2 FY2025 · Q3 FY2025 · Q4 FY2025
Income statement (profit and loss)
| $ million | FY2025 | FY2024 | FY2023 | On the year | Last 8 years |
|---|---|---|---|---|---|
| Revenue | 75,600 | 70,603 | 64,968 | +7.1% | |
| Operating income | 9,832 | 8,523 | 7,706 | +15.4% | |
| Operating margin | 13.0% | 12.1% | 11.9% | ||
| Interest expense | 2,248 | 2,061 | 1,938 | +9.1% | |
| Pre-tax income | 9,832 | 8,523 | 7,706 | +15.4% | |
| Income tax | 2,050 | 1,866 | 1,615 | +9.9% | |
| Effective tax rate | 20.9% | 21.9% | 21.0% | ||
| Net income | 6,784 | 5,760 | 5,242 | +17.8% | |
| Net margin | 9.0% | 8.2% | 8.1% | ||
| Diluted EPS | $28.33 | $22.00 | $18.97 | +28.8% |
Read more
Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.Cash flow
| $ million | FY2025 | FY2024 | FY2023 | On the year | Last 8 years |
|---|---|---|---|---|---|
| Operating cash flow | 12,636 | 10,514 | 9,431 | +20.2% | |
| Capital expenditure | 4,944 | 4,875 | 4,744 | +1.4% | |
| Free cash flow | 7,692 | 5,639 | 4,687 | +36.4% | |
| Free cash flow margin | 10.2% | 8.0% | 7.2% | ||
| Cash from investing | -4,988 | -4,933 | -5,317 | ||
| Cash from financing | -8,550 | -4,582 | -4,094 | ||
| Depreciation and amortisation | 3,523 | 3,312 | 3,077 | +6.4% | |
| Share-based compensation | 401 | 360 | 262 | +11.4% | |
| Buybacks | 10,067 | 6,042 | 3,811 | +66.6% | |
| Dividends paid | 679 | 690 | 661 | -1.6% | |
| Dividend per share | $2.88 | $2.64 | $2.40 | +9.1% | |
| Diluted shares, weighted | 239m | 262m | 276m | -8.5% | |
| Shares outstanding at period end | 225m | 250m | 266m | -10.2% |
Balance sheet
| $ million | FY2025 | FY2024 | FY2023 | On the year | Last 8 years |
|---|---|---|---|---|---|
| Shareholders' equity | -6,027 | -2,499 | -1,774 | ||
| Non-controlling interest | 3,256 | 3,054 | 2,834 | +6.6% | |
| Debt | 46,492 | 43,031 | 39,593 | +8.0% | |
| Operating lease liabilities | 1,853 | 1,863 | 1,903 | -0.5% | |
| Finance lease liabilities | 625 | 624 | 541 | +0.2% | |
| Other liabilities | 14,521 | 13,440 | 13,114 | +8.0% | |
| Total liabilities and equity | 60,720 | 59,513 | 56,211 | +2.0% | |
| Fixed assets | 31,141 | 29,414 | 27,715 | +5.9% | |
| Investments | 485 | 569 | 477 | -14.8% | |
| Cash and equivalents | 1,040 | 1,933 | 935 | -46.2% | |
| Receivables | 10,867 | 10,751 | 9,958 | +1.1% | |
| Inventory | 1,652 | 1,738 | 2,021 | -4.9% | |
| Other assets | 15,535 | 15,108 | 15,105 | +2.8% | |
| Total assets | 60,720 | 59,513 | 56,211 | +2.0% |
10-K for the year ended 31 December 2025, filed 10 February 2026: the filing.